Alternative Carcinogenicity Screening Assay Using Colon Cancer Stem Cells: A Quantitative PCR (qPCR)-Based Prediction System for Colon Carcinogenesis
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The carcinogenicity of chemicals in the environment is a major concern. Recently, numerous studies have attempted to develop methods for predicting carcinogenicity, including rodent and cell-based approaches. However, rodent carcinogenicity tests for evaluating the carcinogenic potential of a chemical to humans are time-consuming and costly. This study focused on the development of an alternative method for predicting carcinogenicity using quantitative PCR (qPCR) and colon cancer stem cells. A toxicogenomic method, mRNA profiling, is useful for predicting carcinogenicity. Using microarray analysis, we optimized 16 predictive gene sets from five carcinogens (azoxymethane, 3,2’-dimethyl-4-aminobiphenyl, N-ethyl-n-nitrosourea, metronidazole, 4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone) used to treat colon cancer stem cell samples. The 16 genes were evaluated by qPCR using 23 positive and negative carcinogens in colon cancer stem cells. Among them, six genes could differentiate between positive and negative carcinogens with a p-value of ≤0.05. Our qPCR-based prediction system for colon carcinogenesis using colon cancer stem cells is cost- and time-efficient. Thus, this qPCR-based prediction system is an alternative to in vivo carcinogenicity screening assays.
Abstract
The carcinogenicity of chemicals in the environment is a major concern. Recently, numerous studies have attempted to develop methods for predicting carcinogenicity, including rodent and cell-based approaches. However, rodent carcinogenicity tests for evaluating the carcinogenic potential of a chemical to humans are time-consuming and costly. This study focused on the development of an alternative method for predicting carcinogenicity using quantitative PCR (qPCR) and colon cancer stem cells. A toxicogenomic method, mRNA profiling, is useful for predicting carcinogenicity. Using microarray analysis, we optimized 16 predictive gene sets from five carcinogens (azoxymethane, 3,2’-dimethyl-4-aminobiphenyl, N-ethyl-n-nitrosourea, metronidazole, 4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone) used to treat colon cancer stem cell samples. The 16 genes were evaluated by qPCR using 23 positive and negative carcinogens in colon cancer stem cells. Among them, six genes could differentiate between positive and negative carcinogens with a p-value of ≤0.05. Our qPCR-based prediction system for colon carcinogenesis using colon cancer stem cells is cost- and time-efficient. Thus, this qPCR-based prediction system is an alternative to in vivo carcinogenicity screening assays.
참고문헌 (22)
- Siegel RL, "Cancer statistics, 2016", CA Cancer J. Clin., 66, pp.7~30 (2016)[DOI]
- Kakarala M, "Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy", J. Clin. Oncol., 26, pp.2813~2820 (2008)[DOI]
- Gusenleitner D, "Genomic models of short-term exposure accurately predict long-term chemical carcinogenicity and identify putative mechanisms of action", PLoS One, 9, pp.e102579~ (2014)[DOI]
- Hartung T, "Toxicology for the twenty-first century", Nature, 460, pp.208~212 (2009)[DOI]
- Knight A, "Animal carcinogenicity studies: implications for the REACH system", Altern. Lab. Anim., 34(Suppl 1), pp.139~147 (2006)
- Caiment F, "Assessing compound carcinogenicity in vitro using connectivity mapping", Carcinogenesis, 35, pp.201~207 (2014)[DOI]
- Fielden MR, "Development and evaluation of a genomic signature for the prediction and mechanistic assessment of nongenotoxic hepatocarcinogens in the rat", Toxicol. Sci., 124, pp.54~74 (2011)[DOI]
- Matsumoto H, "Discrimination of carcinogens by hepatic transcript profiling in rats following 28-day administration", Cancer Inform., 7, pp.253~269 (2009)
- Dontu G, "In vitro propagation and transcriptional profiling of human mammary stem", progenitor cells, 2003, pp.17, 1253~1270
- Bak Y, "IL-32theta inhibits stemness and epithelial-mesenchymal transition of cancer stem cells via the STAT3 pathway in colon cancer", Oncotarget, 7, pp.7307~7317 (2016)
- Ham SY, "Mucin 1-mediated chemo-resistance in lung cancer cells", Oncogenesis, 5, pp.e185~ (2016)[DOI]
- Kwon T, "Peroxiredoxin II is essential for maintaining stemness by redox regulation in liver cancer cells", Stem Cells, 34, pp.1188~1197 (2016)[DOI]
- Reddig PJ, "Clinging to life: cell to matrix adhesion and cell survival", Cancer Metastasis Rev., 24, pp.425~439 (2005)[DOI]
- Rathore K, "Mesenchymal and stem-like cell properties targeted in suppression of chronically-induced breast cell carcinogenesis", Cancer Lett., 333, pp.113~123 (2013)[DOI]
- Waters MD, "Characterizing and predicting carcinogenicity and mode of action using conventional and toxicogenomics methods", Mutat. Res., 705, pp.184~200 (2010)[DOI]
- Khoury L, "Evaluation of four human cell lines with distinct biotransformation properties for genotoxic screening", Mutagenesis, 31, pp.83~96 (2016)
- Rieswijk L, "Exploiting microRNA and mRNA profiles generated in vitro from carcinogen-exposed primary mouse hepatocytes for predicting in vivo genotoxicity and carcinogenicity", Mutagenesis, 31, pp.603~615 (2016)[DOI]
- Schaap MM, "A novel toxicogenomics-based approach to categorize (non-)genotoxic carcinogens", Arch. Toxicol., 89, pp.2413~2427 (2015)[DOI]
- Liu CC, "DiseaseConnect: a comprehensive web server for mechanism-based disease-disease connections", Nucleic Acids Res., 42, pp.W137~W146 (2014)[DOI]
- Persani L, "Patterns of gastrin secretion in patients with nonfunctioning pituitary adenomas", J. Endocrinol. Invest., 14, pp.861~865 (1991)[DOI]
- Syed V, "Profiling estrogen-regulated gene expression changes in normal and malignant human ovarian surface epithelial cells", Oncogene, 24, pp.8128~8143 (2005)[DOI]
- Mithani SK, "Use of integrative epigenetic and cytogenetic analyses to identify novel tumor-suppressor genes in malignant melanoma", Melanoma Res., 21, pp.298~307 (2011)[DOI]